Xiaoneng Mo

8.0k total citations · 1 hit paper
11 papers, 826 citations indexed

About

Xiaoneng Mo is a scholar working on Infectious Diseases, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoneng Mo has authored 11 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 4 papers in Neurology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoneng Mo's work include COVID-19 Clinical Research Studies (8 papers), Long-Term Effects of COVID-19 (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Xiaoneng Mo is often cited by papers focused on COVID-19 Clinical Research Studies (8 papers), Long-Term Effects of COVID-19 (4 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Xiaoneng Mo collaborates with scholars based in China. Xiaoneng Mo's co-authors include Ping Peng, Mu Chen, Chunliang Lei, Shiyue Li, Ruchong Chen, Nanshan Zhong, Hui Peng, Wenhua Jian, Zhuquan Su and Feng Li and has published in prestigious journals such as The Journal of Immunology, European Respiratory Journal and Current Medical Research and Opinion.

In The Last Decade

Xiaoneng Mo

11 papers receiving 810 citations

Hit Papers

Abnormal pulmonary function in COVID-19 patients at time ... 2020 2026 2022 2024 2020 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoneng Mo China 6 522 519 256 111 99 11 826
Jamie Freedman United States 6 424 0.8× 621 1.2× 100 0.4× 56 0.5× 38 0.4× 11 870
Jun Heng Chong United Kingdom 4 271 0.5× 444 0.9× 74 0.3× 35 0.3× 53 0.5× 6 721
Nicholas E. Ingraham United States 16 218 0.4× 513 1.0× 69 0.3× 55 0.5× 66 0.7× 45 964
Suxin Wan China 3 509 1.0× 820 1.6× 56 0.2× 32 0.3× 93 0.9× 5 1.0k
Jinglong Lv China 5 528 1.0× 863 1.7× 58 0.2× 32 0.3× 122 1.2× 6 1.1k
Lieguang Zhang China 4 288 0.6× 598 1.2× 67 0.3× 67 0.6× 41 0.4× 10 809
Renjie Qin China 5 378 0.7× 776 1.5× 54 0.2× 22 0.2× 78 0.8× 8 1.1k
Xilong Deng China 11 294 0.6× 559 1.1× 48 0.2× 24 0.2× 31 0.3× 31 793
Yang Ruishan China 3 369 0.7× 604 1.2× 36 0.1× 25 0.2× 71 0.7× 3 769

Countries citing papers authored by Xiaoneng Mo

Since Specialization
Citations

This map shows the geographic impact of Xiaoneng Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoneng Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoneng Mo more than expected).

Fields of papers citing papers by Xiaoneng Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoneng Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoneng Mo. The network helps show where Xiaoneng Mo may publish in the future.

Co-authorship network of co-authors of Xiaoneng Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoneng Mo. A scholar is included among the top collaborators of Xiaoneng Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoneng Mo. Xiaoneng Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Li, Zhengtu, Yinhu Li, Linghua Li, et al.. (2024). Impact of SARS-CoV-2 infection on respiratory and gut microbiome stability: a metagenomic investigation in long-term-hospitalized COVID-19 patients. npj Biofilms and Microbiomes. 10(1). 126–126. 1 indexed citations
2.
Chen, Mu, Jingwei Liu, Ping Peng, et al.. (2022). Dynamic changes of pulmonary diffusion capacity in survivors of non-critical COVID-19 during the first six months. EClinicalMedicine. 43. 101255–101255. 14 indexed citations
3.
Yan, Qihong, Pingchao Li, Xianmiao Ye, et al.. (2021). Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients. The Journal of Immunology. 206(9). 2146–2159. 24 indexed citations
4.
Liang, Zhenyu, Wenhua Jian, Jianyu Li, et al.. (2021). Changes of quantitative CT-based airway wall dimensions in patients with COVID-19 during early recovery. Journal of Thoracic Disease. 13(3). 1517–1530. 4 indexed citations
5.
Zhang, Yitao, et al.. (2021). Predictors of clinical deterioration in non-severe patients with COVID-19: a retrospective cohort study. Current Medical Research and Opinion. 37(3). 385–391. 13 indexed citations
6.
Mo, Xiaoneng, Wenhua Jian, Zhuquan Su, et al.. (2020). Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. European Respiratory Journal. 55(6). 2001217–2001217. 529 indexed citations breakdown →
7.
Li, Yueping, Zhiwei Xie, Weiyin Lin, et al.. (2020). Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial. Med. 1(1). 105–113.e4. 227 indexed citations
8.
Niu, Xuefeng, Song Li, Pingchao Li, et al.. (2020). Analysis of Peripheral Blood T Cell Receptor and B Cell Receptor Repertoires Reveals Dynamic Adaptive Immune Responses in COVID-19 Patients. SSRN Electronic Journal. 2 indexed citations
9.
Fan, Dejun, et al.. (2018). Prohibitin and the extracellular matrix are upregulated in murine alveolar epithelial cells with LPS‑induced acute injury. Molecular Medicine Reports. 17(6). 7769–7773. 10 indexed citations
10.
Zhou, Tian‐Biao, et al.. (2014). Association of Megsin gene polymorphism with IgA nephropathy risk. Journal of Receptors and Signal Transduction. 35(2). 122–126. 1 indexed citations
11.
Mo, Xiaoneng. (2013). Expression and Clinical Significance of TTF-1 in Lung Adenocarcinoma Tissues. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026